论文部分内容阅读
目的 :观察和验证赛莱乐对椎基底动脉供血不足 (VBI)的治疗作用。方法 :VBI病人 1 3 4例 ,随机分为 2组 ,治疗组给予赛莱乐注射液静脉滴注 ,每日 1次 ,对照组给予盐酸倍他啶加川芎嗪注射液静脉滴注 ,均以 1 4d为 1个疗程并观察疗效。结果 :2组病人有效率、治愈病例平均治愈时间、血液流变性各项指标降低幅度均有显著性差异 (P <0 .0 1 ) ,治疗组明显优于对照组。结论 :赛莱乐治疗VBI病人安全有效 ,明显优于倍他啶的疗效
Objective: To observe and verify the therapeutic effect of sailar on vertebrobasilar insufficiency (VBI). Methods: One hundred and thirty-four patients with VBI were randomly divided into two groups. The treatment group was given Sailai injection intravenously once daily. The control group was given intravenous infusion of betamethasine hydrochloride plus ligustrazine injection, 1 4d for a course of treatment and observe the effect. Results: The effective rate of the two groups, the mean cure time of the cured cases and the decrease of hemorrheological indexes were all significantly different (P <0.01). The treatment group was significantly better than the control group. Conclusion: Salmeterol treatment of VBI patients safe and effective, significantly better than the efficacy of betahistine